ArticleFrontiers in oncology2023

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China.

Zhe Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.